Where does Simplify Medical Pty Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Simplify Medical Pty Ltd ranks #5,472 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Simplify Medical Pty Ltd hold?

Simplify Medical Pty Ltd holds 63 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Simplify Medical Pty Ltd's Innovation Score?

Simplify Medical Pty Ltd has an Innovation Score of 40.3 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Simplify Medical Pty Ltd's patent grant rate increasing or decreasing?

Simplify Medical Pty Ltd's recent grant velocity is -9% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Simplify Medical Pty Ltd's patents?

Simplify Medical Pty Ltd's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Simplify Medical Pty Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Simplify Medical Pty Ltd

Q: What technology areas does Simplify Medical Pty Ltd focus on?

Simplify Medical Pty Ltd's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 60 patents, ranking #96 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 63 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Simplify ranks #5,472 of 49,997 tracked US assignees by granted-patent volume, with 63 patents across 4 technology areas.

#5,472
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.3/100): 18.5
avg claims per patent: -9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5472 · Foreign Corporation #5,472 · 63 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 63 grants
UPPER-Q #5,472/49,997
PHOTO-FINISH Sanford Health
CPC-NARROW A61F · 4 areas
INNOV-PAR 40.3/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sanford Health (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Simplify’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.4 pts (36%) Velocity 7.7 pts (19%) Breadth 7.1 pts (18%) Claim depth 11.1 pts (28%)

Qualcomm Incorporated · highest

85
APT Advanced… · near

40
Prüftechnik Dieter… · near

40
Samsung Electro-Meha… · near

40
Simplify Medical Pty · this assignee

40
Haikou Lili Investment · near

40
3D Lighting… · lowest

7

What this shows Simplify's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Simplify?

Each dot is one of Simplify’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Simplify’s own 18.5 claims/patent is at or below the 20.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Simplify vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Simplify's grants concentrate

Simplify Medical Pty Ltd is a focused PatentsView assignee: 4 CPC subclasses with 95.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (12 grants) versus a trough of 2 in 2020. By volume, Simplify sits between Sanford Health and Taser International, Inc..

Simplify's three-year grant acceleration

Simplify Medical Pty Ltd shows 22 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sanford Health

63
Shenzhen Lute Jia…

63
Siemens Healthcar…

63
Silanna UV Pte

63
Skyhook Wireless

63
Sumitomo Pharma

63
Suncor Energy

63
Taser Internation…

63
Simplify Medical… ◀

63

What this shows Simplify holds 63 patents at rank #5,473, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Simplify

By rank, the assignees closest to #5,473 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Simplify's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Simplify, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Simplify ranks #96 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Prüftechnik Dieter Busch GmbH 40 Samsung Electro-Mehanics Co., Ltd. 40 APT Advanced Polymer Technology Corp. 40 Haikou Lili Investment Co., Ltd. 40

Similar claim depth

Nearest assignees by average claims per patent (18.5 here).

CSL Behring AG 18.5 avg Nanotronics Imaging, Inc. 18.5 avg Omnissa, LLC 18.5 avg Young Optics Inc. 18.5 avg

Simplify's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Simplify Medical Pty Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	4.8%
2017	8	12.7%
2018	9	14.3%
2019	12	19.0%
2020	2	3.2%
2021	5	7.9%
2022	10	15.9%
2023	7	11.1%
2024	5	7.9%
2025partial year	2	3.2%

Which technologies does Simplify Medical Pty Ltd patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 60

A61B - DIAGNOSIS; SURGERY; Identification 18

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C08L - Compositions OF Macromolecular Compounds 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Simplify Medical Pty Ltd's patent record in context - here's where to go next.

Simplify Medical Pty Ltd's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 95.2% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #5,472 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Simplify Medical Pty Ltd against Sanford Health, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.